Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02202668 · ClinicalTrials.gov registry record · NA
Transcutaneous Raman Spectroscope (TRS) Analyses of Diabetic Foot Ulcers
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT02202668 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 5 participants.
The verdict
NCT02202668, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The primary translational research objective of the study is to demonstrate feasibility of using the Transcutaneous Raman Spectroscopy technology in a point-of-care environment. This study represents an initial evaluation of the device in a small cohort of human patients with diabetic foot ulcers. We will be evaluating safety, device design and certain human engineering factors associated with point of care use of the TRS. We anticipate the data we collect in this study will form the basis of later medical device studies.
Interventions
- DEVICE TRS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2014-09 |
| Est. Completion | 2014-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02202668
The ClinicalTrials.gov registry entry for NCT02202668 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TRS is the first listed.
NCT02202668 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02202668 about?
NCT02202668 is a clinical study titled "Transcutaneous Raman Spectroscope (TRS) Analyses of Diabetic Foot Ulcers". The primary translational research objective of the study is to demonstrate feasibility of using the Transcutaneous Raman Spectroscopy technology in a point-of-care environment. This study represents an initial evaluation of the device in a small cohort of human patients with diabetic foot ulcers. W...
What is the current status of trial NCT02202668?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2014-09. Estimated completion is 2014-11.
What interventions are being tested in trial NCT02202668?
The interventions under investigation include: TRS (DEVICE).
Who is sponsoring clinical trial NCT02202668?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.